Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2005 Financial Results
SAN DIEGO, July 21, 2005 /PRNewswire-FirstCall via COMTEX/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report second quarter 2005 financial results after the Nasdaq market closes Wednesday, August 3, 2005. Neurocrine will also host a live conference call and Webcast to discuss its second quarter financial results and provide a Company update Wednesday afternoon, August 3, 2005 at 4:30 PM Eastern Daylight Time (EDT) / 1:30 PM Pacific Daylight Time (PDT). Participants may access the live Conference Call by dialing 1-800-540-0559 (U.S.) or 785-832-1508 (International) and using the Conference ID# NBIX. The call can also be accessed via the Webcast through the Company's website at http://www.neurocrine.com.
If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones-Woodworth or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-888-562-2815 (US) or 402-220-7352 (International) and will be archived until Wednesday, August 17, 2005.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com
SOURCE Neurocrine Biosciences, Inc.
Claudia Jones-Woodworth or Elizabeth Foster, both of Neurocrine Biosciences, Inc., +1-858-617-7600